Multidrug Resistance Studies in Acute Myeloid Leukemia
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Valspodar (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 18 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Jan 2011 Planned number of patients changed from 250 to 2034 as reported by ClinicalTrials.gov.
- 09 Nov 2009 New trial record